Ultromics
Company

Last deal

$18.1M
Local Amount - GBP 23.7M

Amount

Series B

Stage

16.08.2021

Date

6

all rounds

$44.1M

Total amount

General

About Company
Ultromics is an AI-powered diagnostic aid that helps cardiologists improve the diagnosis of coronary heart disease by more than 90%.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2017

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

Ultromics is a leader in AI for echocardiography, offering a cloud-based platform called EchoGo that provides fully automated, advanced echo analysis including critical advanced measures recommended by guidelines. Their technology is FDA-cleared and CE-marked, and trusted by world-renowned organizations such as Mayo Clinic and the NHS England. With Ultromics' AI technology, all providers can now make precise, accurate, and timely diagnoses of heart failure, enabling earlier detection and risk stratification for better outcomes, lower costs, and improved patient care.
Contacts

location

Phone number

Social url